Serotonin-RhoA/ROCK axis promotes acinar-to-ductal metaplasia in caerulein-induced chronic pancreatitis

[Display omitted] •5-HT level in pancreatic tissues increases in caerulein-induced CP mice.•5-HT promotes ADM formation and PSCs activation in vitro and in vivo.•5-HT promotes ADM and pancreatic fibrosis by regulating RhoA/ROCK signaling.•Quercetin inhibits CP induced-ADM and -fibrosis via inhibitin...

Full description

Saved in:
Bibliographic Details
Published inBiomedicine & pharmacotherapy Vol. 125; p. 109999
Main Authors Tao, Xufeng, Chen, Qing, Li, Ning, Xiang, Hong, Pan, Yue, Qu, Yueyang, Shang, Dong, Go, Vay Liang W., Xue, Jing, Sun, Yongwei, Zhang, Zhigang, Guo, Junchao, Xiao, Gary Guishan
Format Journal Article
LanguageEnglish
Published France Elsevier Masson SAS 01.05.2020
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •5-HT level in pancreatic tissues increases in caerulein-induced CP mice.•5-HT promotes ADM formation and PSCs activation in vitro and in vivo.•5-HT promotes ADM and pancreatic fibrosis by regulating RhoA/ROCK signaling.•Quercetin inhibits CP induced-ADM and -fibrosis via inhibiting 5-HT release. The underlying molecular mechanisms of chronic pancreatitis (CP) developing into pancreatic ductal adenocarcinoma (PDAC) remain largely unknown. Here we show that the level of serotonin in mouse pancreatic tissues is upregulated in caerulein-induced CP mice. In vitro study demonstrates that serotonin promotes the formation of acinar-to-ductal metaplasia (ADM) and the activation of pancreatic stellate cells (PSCs), which results from the activation of RhoA/ROCK signaling cascade. Activation of this signaling cascade increases NF-κB nuclear translocation and α-SMA expression, which further enhance the inflammatory responses and fibrosis in pancreatic tissues. Intriguingly, quercetin inhibits both ADM lesion and PSCs activation in vitro and in vivo via its inhibitory effect on serotonin release. Our findings underscore the instrumental role of serotonin-mediated activation of RhoA/ROCK signaling pathway in development of PDAC from CP and highlight a potential to impede PDAC development by disrupting tumor-promoting functions of serotonin.
ISSN:0753-3322
1950-6007
DOI:10.1016/j.biopha.2020.109999